Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Endocrine 1

Conditions

Ovarian Neoplasms 5Fallopian Tube Neoplasms 4Peritoneal Neoplasms 3Hyperthermia 3Carcinoma, Ovarian Epithelial 3Recurrence 1Mesothelioma 1Gastrointestinal Neoplasms 1Colonic Neoplasms 1Clear-cell metastatic renal cell carcinoma 1Carcinoma, Renal Cell 1Carcinoma 1Brenner Tumor 1Appendiceal Neoplasms 1Adrenocortical Carcinoma 1Abdominal Neoplasms 1

Interventions

Mitotane 4Cisplatin 3pembrolizumab 2cixutumumab 2Etoposide 2Doxorubicin 2Dichlorodiphenyldichloroethane 2sodium thiosulfate 1relacorilant 1pegfilgrastim 1milademetan 1gossypol acetic acid 1cabozantinib 1avelumab 1antineoplaston AS 2-1 1antineoplaston A10 1Sunitinib 1Streptozocin 1Platinum 1Nivolumab 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Fentanyl 1Ethane 1Cytoreduction Surgical Procedures 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Adrenocortical Carcinoma × Cytoreduction Surgical Procedures × Clear all
NCT01833832 2019-07-30

Surgery and Heated Chemotherapy for Adrenocortical Carcinoma

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
11 enrolled 14 charts
EndocrineGynecologic

Hyperthermia, Peritoneal Neoplasms, Adrenocortical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡